Hyperimmunoglobulin D syndrome (HIDS) is a rare hereditary autoinflammatory disease characterized by attacks lasting 3-7 days recurring every 4-8 weeks. The most important finding is recurring fever, which may be accompanied by headache, myalgia, arthralgia, abdominal pain, vomiting, diarrhea, cervical lymphadenopathy, aphthous ulcers, and skin rash. 1 It develops as a result of mutations of the gene coding for the enzyme mevalonate kinase (MVK). 2 The gene is located on the long arm of the 12 th chromosome (12q24). 3 HIDS diagnosis is based on reduction in MVK enzyme activity or by detecting the mutations of the MVK gene causing the disease.
During attacks, acute phase response is monitored in patients. Laboratory investigations show leukocytosis, increased erythrocyte sedimentation rate, and increased levels of both C reactive protein and serum amyloid A. 4 Increased polyclonal serum immunoglobulin (Ig)D is accepted as a distinguishing feature of the disease; however, it is not diagnostic. Increased serum IgA levels are found in 80% of HIDS patients. 5 During attacks, urinary excretion of mevalonic acid increases, and measurements have diagnostic value. 6 Differential diagnosis of HIDS includes familial Mediterranean fever (FMF), tumor necrosis factor receptor periodic syndrome, adult Still's disease, juvenile idiopathic arthritis, rheumatic fever, and Behçet's disease.
To our knowledge, there is no evidencebased treatment regime for HIDS. In the literature; colchicine, steroids, and non-steroidal anti-inflammatory drug treatments have been reported. Recently, positive results have been observed in randomized studies of simvastatin, anakinra, thalidomide, and etanercept. 7, 8 In this article, we present a HIDS case with recurring fever attacks who previously had a diagnosis of FMF and remained reluctant to treatment.
CASE REPORT
The patient was a 21-year-old single female. She had complaints of fever attacks, up to 39-40 degrees Celsius with chills, beginning at three years of age. She also complained of accompanying knee joint pain, nauseavomiting, abdominal pain, and diarrhea. The fever attacks lasted three days and recurred every 4-6 weeks. The patient's family history was researched, and a sibling also had joint pain and fever attacks.
Investigations during fever attacks revealed a sedimentation rate of 60 mm/h and C reactive protein of 10 mg/L. During the attack, the white cell count was 18,000 mm 3 with sputum, urine, and blood cultures free of any microorganism. Hepatitis B surface antigen, anti-hepatitis C virus, Brucella, and Salmonella were all negative. Biochemical tests were normal. Antinuclear antibody was negative; rheumatoid factor was <20 IU.
Genetic analysis of the patient detected K695R heterozygote mutation of Mediterranean fever gene 10 exon, FMF diagnosis was made, and colchicine treatment was begun. When the fever attacks continued in spite of colchicine treatment, the patient was evaluated for other periodic fever syndromes.
The patient had IgD (serum): <15 IU/mL (0-100 IU/mL) and IgA (serum): 139 mg/dL (45-380 mg/dL). Genetic analysis showed homozygotic S53N mutation on MVK gene 3 rd exon, and the HIDS diagnosis was made. Our laboratory conditions were incapable of evaluating MVK enzyme activity, and mevalonic acid levels were not measured in the urine because the patient was in a non-attack period.
DISCUSSION
Hyperimmunoglobulin D syndrome develops as a result of mutations of the gene coding for the enzyme MVK, which plays a role in cholesterol and isoprenoid synthesis. 9 The syndrome has an autosomal recessive trait with half of the siblings being affected. 2 In our case, one sibling had a history of fever attacks but no firm diagnosis.
There are 65 different mutations found on the MVK gene. The most common mutations occurring with the disease (V377I, I268T, H20P/N, P167L) are responsible for 71.5% of cases. 10 No relationship has been found between a certain mutation and the severity, onset of symptoms, and attack frequency in HIDS.
11 HIDS patients are reported to be mostly European, especially of Dutch heritage. The most common mutation in the Dutch populations is reported to be p.V377I. 12 Heterozygotic mutation of the MVK gene is found in 80% of HIDS patients. In our Figure 1 . Mevalonate kinase gene analysis of the patient. case, the mutation was homozygotic S52N on the 3 rd exon of the MVK gene ( Figure 1 ). The few cases in the literature from Turkey have G326R, V377I, I268T, T322S, M680I, R277C mutations. 13, 14 Some of these cases were thought to have FMF and were given colchicine. When there was no response to treatment, the HIDS diagnosis was made. 13, 15 Our patient was diagnosed with FMF. When fever attacks did not regress with treatment, genetic analysis was used to reach a diagnosis of HIDS.
Laboratory investigations of patients with fever attacks are helpful for differential diagnosis. Most HIDS patients have increased IgD levels although our case had normal levels of 22%. 3 In addition, mevalonic acid in urine and serum mevalonate kinase levels can be used for firm diagnosis of HIDS.
Familial Mediterranean fever is the most frequently seen periodic fever syndrome in our country. No matter what age, cases with severe complaints that do not respond well to colchicine should be investigated for other autoinflammatory diseases. Even if serum IgD and IgA levels are normal, other periodic fever syndromes, such as HIDS, should be considered.
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